Transforming Medicine: Colin Hill

Our capacity to create a world free from cancer is moving faster than the speed of life. Find out how GNS Healthcare co-founder and CEO, Colin Hill sees the possibility of creating a world free from cancer by using big data to deliver on the promise of personalized medicine.

:: ABOUT COLIN HILL ::

Colin Hill co-founded GNS Healthcare in 2000 and has served as CEO since then. He brings years of hands-on scientific experience to his role, with expertise in the areas of computational physics, systems biology, and personalized medicine. He also serves as Chairman of GNS Healthcare's parent company Via Science, a leading big data analytics company focused on business intelligence, finance, and economic forecasting. He also serves on the Board of Directors of AesRx, a biopharmaceutical company dedicated to the development of new treatment for sickle cell disease. Colin was the founding chairman of O'Reilly Media's Strata Rx, one of the first healthcare big data conferences.

In 2004, Colin was named to MIT Technology Review's TR100 list of the top innovators in the world under the age of 35. He is a frequent speaker at national and international scientific and industry conferences and has been quoted in in numerous publications and television programs, including The Wall Street Journal, CNBC Morning Call, Nature, Forbes, Wired, and The Economist. He graduated from Virginia Tech with a degree in physics and earned masters degrees in physics from both McGill University and Cornell University.

To view Colin Hill's bio on the Transforming Medicine website, visit: transformingmedicine.org/about

Тэги:

#Medicine_(Field_Of_Study)

Скачать видео